Most previous studies have focused on evaluating circulating IGFBP-3, and almost none have systematically investigated the level of this important protein in breast tissues from patients with invasive cancer and benign breast diseases (BBDs). The gene discussed is IGFBP3; the disease is breast fibrocystic disease.